Surgery Partners, Inc. (SGRY)
- Previous Close
27.09 - Open
27.31 - Bid 26.51 x 300
- Ask 26.63 x 300
- Day's Range
26.50 - 27.57 - 52 Week Range
22.05 - 45.79 - Volume
1,020,288 - Avg. Volume
965,391 - Market Cap (intraday)
3.379B - Beta (5Y Monthly) 2.76
- PE Ratio (TTM)
2,659.00 - EPS (TTM)
0.01 - Earnings Date Jul 30, 2024 - Aug 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
41.09
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
www.surgerypartners.com10,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SGRY
Performance Overview: SGRY
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SGRY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SGRY
Valuation Measures
Market Cap
3.38B
Enterprise Value
6.35B
Trailing P/E
2.66k
Forward P/E
26.32
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.20
Price/Book (mrq)
1.72
Enterprise Value/Revenue
2.34
Enterprise Value/EBITDA
14.38
Financial Highlights
Profitability and Income Statement
Profit Margin
0.02%
Return on Assets (ttm)
4.00%
Return on Equity (ttm)
4.76%
Revenue (ttm)
2.79B
Net Income Avi to Common (ttm)
600k
Diluted EPS (ttm)
0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
185.2M
Total Debt/Equity (mrq)
94.41%
Levered Free Cash Flow (ttm)
149.59M
Research Analysis: SGRY
Company Insights: SGRY
SGRY does not have Company Insights